- Tungiasis is a skin disease caused by fleas.
- The flea is called Tunga penetrans.
- It causes pain, burning and strong itching.
- The feet often have the parasite.
- Millions in Latin America, Caribbean and Africa suffer.
- Children and older adults suffer most from it.
- PAHO published the first treatment guide.
- PAHO recommends low-viscosity dimethicone as treatment.
- If dimethicone is unavailable, use ivermectin.
- Never pull fleas out with needles or pins.
Difficult words
- tungiasis — a disease caused by a sand flea.
- disease — a health problem in the body.
- skin — the outer layer of the body.
- itch — to have a tickling feeling on the skin.
- cream — a thick liquid for skin.
- treat — to help someone feel better.
- rules — guidelines to follow.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How can we help people with tungiasis?
- Why do you think poor areas have more cases?
- What do you think of the new treatment rules?
Related articles
Blocking a key immune signal may prolong post-surgery pain
A study led by Geoffroy Laumet found that blocking the immune molecule TNF-α after surgery in mice made pain last longer. The authors warn this does not mean stopping all anti-inflammatory treatment and call for targeted approaches.
Vitamin D may slow diabetes for some people
A new analysis of a large US trial suggests vitamin D supplements might delay progression from prediabetes to type 2 diabetes for people with certain vitamin D receptor gene variations. Researchers warn against taking high doses without medical advice.
How Long-Term Singlehood Affects Young Adults
A study tracked more than 17,000 young people in Germany and the UK from ages 16 to 29. It found that long periods of singlehood are linked to falling life satisfaction and rising loneliness, while starting a first relationship improves well-being.
New inflammatory pathway may explain some rheumatoid arthritis treatment failures
A Washington State University study found that a lesser-known TWEAK–Fn14 pathway can join with TNF to increase inflammation. Blocking Fn14 reduced this surge and may explain why some patients do not respond to TNF inhibitors.